Please login to the form below

Not currently logged in
Email:
Password:

varenicline

This page shows the latest varenicline news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

The EAGLES study - published in The Lancet - backed the safety and efficacy of Pfizer's Chantix/Champix (varenicline) and GlaxoSmithKline's Zyban (bupropion) as well as nicotine replacement therapies in helping

Latest news

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • On our best behaviour On our best behaviour

    Meanwhile, for non-nicotine pharmacotherapies with proven efficacy, such as Pfizer’s Champix (varenicline), their impact on effecting behaviour change depends almost entirely on reimbursement.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....